The public stock float for Turn Therapeutics (TTRX)—representing the total number of shares available for public trading by retail and institutional investors—reflects the distribution agreed upon during its initial direct listing and subsequent funding arrangements. A significant portion of the total authorized common stock remains closely held by founders, executive management, and strategic private funding partners, while the active public float fluctuates daily based on trading volume and institutional block transactions on the Nasdaq exchange.